These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 19517467)
1. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467 [TBL] [Abstract][Full Text] [Related]
2. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication. Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963 [TBL] [Abstract][Full Text] [Related]
3. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744 [TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Huh JW; Lee JH; Kim HR Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783 [TBL] [Abstract][Full Text] [Related]
7. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ; Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987 [TBL] [Abstract][Full Text] [Related]
8. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma. Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Lo DS; Pollett A; Siu LL; Gallinger S; Burkes RL Cancer; 2008 Jan; 112(1):50-4. PubMed ID: 18008365 [TBL] [Abstract][Full Text] [Related]
10. [Study on independent factors on the prognosis of colorectal carcinoma: TNM stage, tumor budding, perineural invasion, peritumoral-lymphocytic infiltration and urine glucose]. Xu FY; Dong JK; Zhu YM; Qu MJ; Wang FJ; Jin YS; Ren GP; Lai MD Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):366-9. PubMed ID: 16053766 [TBL] [Abstract][Full Text] [Related]
11. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. Gosens MJ; van Krieken JH; Marijnen CA; Meershoek-Klein Kranenbarg E; Putter H; Rutten HJ; Bujko K; van de Velde CJ; Nagtegaal ID; Clin Gastroenterol Hepatol; 2007 Aug; 5(8):997-1003. PubMed ID: 17544876 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Funada Y; Noguchi T; Kikuchi R; Takeno S; Uchida Y; Gabbert HE Oncol Rep; 2003; 10(2):309-13. PubMed ID: 12579264 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647 [TBL] [Abstract][Full Text] [Related]
14. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma. Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138 [TBL] [Abstract][Full Text] [Related]
15. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of colorectal carcinoma in the elderly after radical surgery]. Liang JW; Bai XF; Zhou ZX; Zhao DB; Wang CF; Zhao P Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1467-70. PubMed ID: 18953852 [TBL] [Abstract][Full Text] [Related]
17. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more. Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303 [TBL] [Abstract][Full Text] [Related]
18. The impact of T and N stage on long-term survival of rectal cancer patients in the community. Kozak KR; Moody JS J Surg Oncol; 2008 Sep; 98(3):161-6. PubMed ID: 18615481 [TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay. Douard R; Wind P; Sales JP; Landi B; Berger A; Benichou J; Gayral F; Loric S; Cugnenc PH Surgery; 2006 Apr; 139(4):556-62. PubMed ID: 16627067 [TBL] [Abstract][Full Text] [Related]
20. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Yoshida K; Yoshimatsu K; Otani T; Yokomizo H; Ogawa K Anticancer Res; 2008; 28(3B):1773-8. PubMed ID: 18630458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]